{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T12:23:50Z","timestamp":1769171030219,"version":"3.49.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2018,7,23]],"date-time":"2018-07-23T00:00:00Z","timestamp":1532304000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2018,7,23]],"date-time":"2018-07-23T00:00:00Z","timestamp":1532304000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["1T32 DA 022981"],"award-info":[{"award-number":["1T32 DA 022981"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Qual Life Res"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1007\/s11136-018-1941-1","type":"journal-article","created":{"date-parts":[[2018,7,23]],"date-time":"2018-07-23T04:23:35Z","timestamp":1532319815000},"page":"3021-3035","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Evaluation of opioid use among patients with back disorders and arthritis"],"prefix":"10.1007","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7776-6157","authenticated-orcid":false,"given":"Corey J.","family":"Hayes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nalin","family":"Payakachat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chenghui","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,7,23]]},"reference":[{"issue":"7","key":"1941_CR1","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1002\/art.39692","volume":"68","author":"JM Hootman","year":"2016","unstructured":"Hootman, J. M., Helmick, C. G., Barbour, K. E., Theis, K. A., & Boring, M. A. (2016). Updated projected prevalence of self-reported doctor-diagnosed arthritis and arthritis-attributable activity limitation among US adults, 2015\u20132040. Arthritis & Rheumatology (Hoboken, N.J.), 68(7), 1582\u20131587. https:\/\/doi.org\/10.1002\/art.39692 .","journal-title":"Arthritis & Rheumatology (Hoboken, N.J.)"},{"issue":"3","key":"1941_CR2","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1001\/archinternmed.2008.543","volume":"169","author":"JK Freburger","year":"2009","unstructured":"Freburger, J. K., Holmes, G. M., Agans, R. P., Jackman, A. M., Darter, J. D., Wallace, A. S., et al. (2009). The rising prevalence of chronic low back pain. Archives of Internal Medicine, 169(3), 251\u2013258. https:\/\/doi.org\/10.1001\/archinternmed.2008.543 .","journal-title":"Archives of Internal Medicine"},{"key":"1941_CR3","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.2147\/JPR.S130913","volume":"10","author":"PB Landsman-Blumberg","year":"2017","unstructured":"Landsman-Blumberg, P. B., Katz, N., Gajria, K., D\u2019Souza, A. O., Chaudhari, S. L., Yeung, P. P., et al. (2017). Health care resource use and cost differences by opioid therapy type among chronic noncancer pain patients. Journal of Pain Research, 10, 1713\u20131722. https:\/\/doi.org\/10.2147\/JPR.S130913 .","journal-title":"Journal of Pain Research"},{"issue":"5","key":"1941_CR4","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1007\/s10067-016-3239-4","volume":"35","author":"JA Zamora-Legoff","year":"2016","unstructured":"Zamora-Legoff, J. A., Achenbach, S. J., Crowson, C. S., Krause, M. L., Davis, J. M., & Matteson, E. L. (2016). Opioid use in patients with rheumatoid arthritis 2005\u20132014: A population-based comparative study. Clinical Rheumatology, 35(5), 1137\u20131144. https:\/\/doi.org\/10.1007\/s10067-016-3239-4 .","journal-title":"Clinical Rheumatology"},{"issue":"10","key":"1941_CR5","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1002\/acr.22360","volume":"66","author":"EA Wright","year":"2014","unstructured":"Wright, E. A., Katz, J. N., Abrams, S., Solomon, D. H., & Losina, E. (2014). Trends in prescription of opioids from 2003 to 2009 in persons with knee osteoarthritis. Arthritis Care & Research, 66(10), 1489\u20131495. https:\/\/doi.org\/10.1002\/acr.22360 .","journal-title":"Arthritis Care & Research"},{"issue":"17","key":"1941_CR6","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1001\/jamainternmed.2013.8992","volume":"173","author":"JN Mafi","year":"2013","unstructured":"Mafi, J. N., McCarthy, E. P., Davis, R. B., & Landon, B. E. (2013). Worsening trends in the management and treatment of back pain. JAMA Internal Medicine, 173(17), 1573. https:\/\/doi.org\/10.1001\/jamainternmed.2013.8992 .","journal-title":"JAMA Internal Medicine"},{"issue":"7","key":"1941_CR7","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1097\/BRS.0000000000000249","volume":"39","author":"LE Chaparro","year":"2014","unstructured":"Chaparro, L. E., Furlan, A. D., Deshpande, A., Mailis-Gagnon, A., Atlas, S., & Turk, D. C. (2014). Opioids compared with placebo or other treatments for chronic low back pain. Spine, 39(7), 556\u2013563. https:\/\/doi.org\/10.1097\/BRS.0000000000000249 .","journal-title":"Spine"},{"key":"1941_CR8","doi-asserted-by":"publisher","DOI":"10.23970\/AHRQEPCERTA218","volume-title":"The effectiveness and risks of long-term opioid treatment of chronic pain","author":"R Chou","year":"2014","unstructured":"Chou, R., Rick Deyo, F., Beth Devine, M., Ryan Hansen, R., Sullivan, S., Jarvik, J. G., et al. (2014). The effectiveness and risks of long-term opioid treatment of chronic pain. Rockville, MD: Agency for Healthcare Research and Quality (US)."},{"issue":"1","key":"1941_CR9","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1093\/bja\/aen103","volume":"101","author":"H Breivik","year":"2008","unstructured":"Breivik, H., Borchgrevink, P. C., Allen, S. M., Rosseland, L. A., Romundstad, L., Breivik Hals, E. K., et al.(2008). Assessment of pain. British Journal of Anaesthesia, 101(1), 17\u201324. https:\/\/doi.org\/10.1093\/bja\/aen103 .","journal-title":"British Journal of Anaesthesia"},{"issue":"1","key":"1941_CR10","doi-asserted-by":"publisher","first-page":"S38","DOI":"10.1016\/S0885-3924(02)00411-6","volume":"24","author":"N Katz","year":"2002","unstructured":"Katz, N. (2002). The impact of pain management on quality of life. Journal of Pain and Symptom Management, 24(1), S38\u2013S47. https:\/\/doi.org\/10.1016\/S0885-3924(02)00411-6 .","journal-title":"Journal of Pain and Symptom Management"},{"key":"1941_CR11","unstructured":"Agency for Healthcare Research and Quality. (n.d.). Medical Expenditure Panel Survey background. Retrieved August 10, 2016, from https:\/\/meps.ahrq.gov\/mepsweb\/about_meps\/survey_back.jsp ."},{"key":"1941_CR12","unstructured":"Agency for Healthcare Research and Quality. (n.d.). Medical Expenditure Panel Survey home. Retrieved May 3, 2016, from http:\/\/meps.ahrq.gov\/mepsweb\/ ."},{"key":"1941_CR13","unstructured":"Medical Expenditure Panel Survey Public Use File Search Results. (n.d.). Retrieved January 11, 2017, from https:\/\/meps.ahrq.gov\/mepsweb\/data_stats\/download_data_files_results.jsp?cboDataYear=All&cboDataTypeY=1%2CHousehold+Full+Year+File&buttonYearandDataType=Search&cboPufNumber=All&SearchTitle=Medical+Conditions"},{"key":"1941_CR14","unstructured":"Multum Source Information. (n.d.). Retrieved from https:\/\/www.nlm.nih.gov\/research\/umls\/sourcereleasedocs\/current\/MMSL\/ ."},{"key":"1941_CR15","unstructured":"Lemke, M. (2015). Prescription opioid use in the U.S. in 2012: Characterizing sustained vs. infrequent use using the medical expenditure panel survey. Retrieved from http:\/\/www.lexjansen.com\/sesug\/2015\/182_Final_PDF.pdf ."},{"issue":"3","key":"1941_CR16","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1111\/1475-6773.12263","volume":"50","author":"EL Stockbridge","year":"2015","unstructured":"Stockbridge, E. L., Suzuki, S., & Pag\u00e1n, J. A. (2015). Chronic pain and health care spending: An analysis of longitudinal data from the Medical Expenditure Panel Survey. Health Services Research, 50(3), 847\u2013870. https:\/\/doi.org\/10.1111\/1475-6773.12263 .","journal-title":"Health Services Research"},{"key":"1941_CR17","unstructured":"IMS Health. (n.d.). IMS LifeLink Health Plan Claims Database: Overview and study design issues. Retrieved November 21, 2015, from http:\/\/www.uams.edu\/TRI\/hsrcore\/Lifelink_Health_Plan_Claims_Data_DesignIssues_wcost_April2010%5B1%5D.pdf ."},{"key":"1941_CR18","unstructured":"U.S Department of Justice Drug Enforcement Administration Office of Diversion Control. (2014). Rules\u20142014\u2014Final rule: Rescheduling of hydrocodone combination products from schedule III to schedule II. Retrieved August 11, 2016, from http:\/\/www.deadiversion.usdoj.gov\/fed_regs\/rules\/2014\/fr0822.htm ."},{"issue":"10","key":"1941_CR19","doi-asserted-by":"publisher","first-page":"265","DOI":"10.15585\/mmwr.mm6610a1","volume":"66","author":"A Shah","year":"2017","unstructured":"Shah, A., Hayes, C. J., & Martin, B. C. (2017). Characteristics of initial prescription episodes and likelihood of long-term opioid use \u2014 United States, 2006\u20132015. MMWR Morbidity and Mortality Weekly Report, 66(10), 265\u2013269. https:\/\/doi.org\/10.15585\/mmwr.mm6610a1 .","journal-title":"MMWR Morbidity and Mortality Weekly Report"},{"issue":"11","key":"1941_CR20","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1002\/pds.3851","volume":"24","author":"CJ Hayes","year":"2015","unstructured":"Hayes, C. J., Hudson, T. J., Phillips, M. M., Bursac, Z., Williams, J. S., Austin, M. A., et al. (2015). The influence of propoxyphene withdrawal on opioid use in veterans. Pharmacoepidemiology and Drug Safety, 24(11), 1180\u20131188. https:\/\/doi.org\/10.1002\/pds.3851 .","journal-title":"Pharmacoepidemiology and Drug Safety"},{"issue":"1","key":"1941_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.rr6501e1er","volume":"65","author":"D Dowell","year":"2016","unstructured":"Dowell, D., Haegerich, T. M., & Chou, R. (2016). CDC guideline for prescribing opioids for chronic pain \u2014 United States, 2016. MMWR. Recommendations and Reports, 65(1), 1\u201349. https:\/\/doi.org\/10.15585\/mmwr.rr6501e1er .","journal-title":"MMWR. Recommendations and Reports"},{"issue":"2","key":"1941_CR22","doi-asserted-by":"publisher","first-page":"22","DOI":"10.3390\/healthcare5020022","volume":"5","author":"C Hayes","year":"2017","unstructured":"Hayes, C., Bhandari, N., Kathe, N., & Payakachat, N. (2017). Reliability and Validity of the medical outcomes study short form-12 version 2 (SF-12v2) in adults with non-cancer pain. Healthcare, 5(2), 22. https:\/\/doi.org\/10.3390\/healthcare5020022 .","journal-title":"Healthcare"},{"key":"1941_CR23","volume-title":"How to score version 2 of the SF-12 health survey (with a supplement documenting version 1)","author":"J Ware","year":"2005","unstructured":"Ware, J. (2005). How to score version 2 of the SF-12 health survey (with a supplement documenting version 1). Lincoln, RI: QualityMetric Inc."},{"issue":"6","key":"1941_CR24","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1007\/s11136-009-9483-1","volume":"18","author":"NC Cheak-Zamora","year":"2009","unstructured":"Cheak-Zamora, N. C., Wyrwich, K. W., & McBride, T. D. (2009). Reliability and validity of the SF-12v2 in the medical expenditure panel survey. Quality of Life Research, 18(6), 727\u2013735. https:\/\/doi.org\/10.1007\/s11136-009-9483-1 .","journal-title":"Quality of Life Research"},{"key":"1941_CR25","unstructured":"Weblet Importer. (n.d.). Retrieved November 15, 2017, from http:\/\/gim.med.ucla.edu\/FacultyPages\/Hays\/utils\/sf12v2-1.sas ."},{"issue":"12","key":"1941_CR26","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1002\/acr.22392","volume":"66","author":"MM Ward","year":"2014","unstructured":"Ward, M. M., Guthrie, L. C., & Alba, M. I. (2014). Clinically important changes in short form 36 health survey scales for use in rheumatoid arthritis clinical trials: The impact of low responsiveness. Arthritis Care & Research, 66(12), 1783\u20131789. https:\/\/doi.org\/10.1002\/acr.22392 .","journal-title":"Arthritis Care & Research"},{"key":"1941_CR27","doi-asserted-by":"publisher","DOI":"10.1097\/BRS.0000000000002298","author":"MJ D\u00edaz-Arribas","year":"2017","unstructured":"D\u00edaz-Arribas, M. J., Fern\u00e1ndez-Serrano, M., Royuela, A., Kovacs, F. M., Gallego-Izquierdo, T., Ramos-S\u00e1nchez, M., et al. (2017). Minimal clinically important difference in quality of life for patients with low back pain. SPINE. https:\/\/doi.org\/10.1097\/BRS.0000000000002298 .","journal-title":"SPINE"},{"issue":"3","key":"1941_CR28","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.joca.2006.09.001","volume":"15","author":"A Escobar","year":"2007","unstructured":"Escobar, A., Quintana, J. M., Bilbao, A., Ar\u00f3stegui, I., Lafuente, I., & Vidaurreta, I. (2007). Responsiveness and clinically important differences for the WOMAC and SF-36 after total knee replacement. Osteoarthritis and Cartilage, 15(3), 273\u2013280. https:\/\/doi.org\/10.1016\/j.joca.2006.09.001 .","journal-title":"Osteoarthritis and Cartilage"},{"key":"1941_CR29","volume-title":"Statistical power analysis for the behavioral sciences","author":"J Cohen","year":"1977","unstructured":"Cohen, J. (1977). Statistical power analysis for the behavioral sciences. New York: Academic Press."},{"key":"1941_CR30","unstructured":"SF-12v2TM Health Survey. (n.d.). Retrieved from http:\/\/www.cscc.unc.edu\/codi\/forms\/UNLICOMMSFHSF12ShortFormHealthSurvey03192010.pdf ."},{"issue":"6","key":"1941_CR31","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/0895-4356(92)90133-8","volume":"45","author":"RA Deyo","year":"1992","unstructured":"Deyo, R. A., Cherkin, D. C., & Ciol, M. A. (1992). Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. Journal of Clinical Epidemiology, 45(6), 613\u2013619.","journal-title":"Journal of Clinical Epidemiology"},{"issue":"12","key":"1941_CR32","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1002\/pds.1673","volume":"17","author":"PC Austin","year":"2008","unstructured":"Austin, P. C. (2008). Goodness-of-fit diagnostics for the propensity score model when estimating treatment effects using covariate adjustment with the propensity score. Pharmacoepidemiology and Drug Safety, 17(12), 1202\u20131217. https:\/\/doi.org\/10.1002\/pds.1673 .","journal-title":"Pharmacoepidemiology and Drug Safety"},{"issue":"3","key":"1941_CR33","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1080\/00273171.2011.568786","volume":"46","author":"PC Austin","year":"2011","unstructured":"Austin, P. C. (2011). An introduction to propensity score methods for reducing the effects of confounding in observational studies. Multivariate Behavioral Research, 46(3), 399\u2013424. https:\/\/doi.org\/10.1080\/00273171.2011.568786 .","journal-title":"Multivariate Behavioral Research"},{"issue":"18","key":"1941_CR34","doi-asserted-by":"publisher","first-page":"2395","DOI":"10.1161\/CIRCULATIONAHA.106.682658","volume":"117","author":"MP LaValley","year":"2008","unstructured":"LaValley, M. P. (2008). Logistic regression. Circulation, 117(18), 2395\u20132399. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.106.682658 .","journal-title":"Circulation"},{"issue":"7","key":"1941_CR35","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1002\/sim.4780090710","volume":"9","author":"Y Hochberg","year":"1990","unstructured":"Hochberg, Y., & Benjamini, Y. (1990). More powerful procedures for multiple significance testing. Statistics in Medicine, 9(7), 811\u2013818. https:\/\/doi.org\/10.1002\/sim.4780090710 .","journal-title":"Statistics in Medicine"},{"issue":"5","key":"1941_CR36","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1001\/jama.2012.193412","volume":"309","author":"SL Whittle","year":"2013","unstructured":"Whittle, S. L., Richards, B. L., & Buchbinder, R. (2013). Opioid analgesics for rheumatoid arthritis pain. JAMA, 309(5), 485. https:\/\/doi.org\/10.1001\/jama.2012.193412 .","journal-title":"JAMA"},{"issue":"9","key":"1941_CR37","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1001\/jama.2018.0899","volume":"319","author":"EE Krebs","year":"2018","unstructured":"Krebs, E. E., Gravely, A., Nugent, S., Jensen, A. C., DeRonne, B., Goldsmith, E. S., et al. (2018). Effect of opioid vs nonopioid medications on pain-related function in patients with chronic back pain or hip or knee osteoarthritis pain. JAMA, 319(9), 872. https:\/\/doi.org\/10.1001\/jama.2018.0899 .","journal-title":"JAMA"},{"issue":"1","key":"1941_CR38","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1097\/AAP.0000000000000022","volume":"39","author":"BD Sites","year":"2014","unstructured":"Sites, B. D., Beach, M. L., & Davis, M. A. (2014). Increases in the use of prescription opioid analgesics and the lack of improvement in disability metrics among users. Regional Anesthesia and Pain Medicine, 39(1), 6\u201312. https:\/\/doi.org\/10.1097\/AAP.0000000000000022 .","journal-title":"Regional Anesthesia and Pain Medicine"},{"issue":"7","key":"1941_CR39","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1111\/pme.12702","volume":"16","author":"GP Bostick","year":"2015","unstructured":"Bostick, G. P., Toth, C., Carr, E. C. J., Stitt, L. W., Morley-Forster, P., Clark, A. J., et al. (2015). Physical functioning and opioid use in patients with neuropathic pain. Pain Medicine (Malden, Mass.), 16(7), 1361\u20131368. https:\/\/doi.org\/10.1111\/pme.12702 .","journal-title":"Pain Medicine (Malden, Mass.)"},{"key":"1941_CR40","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1186\/s12916-014-0175-5","volume":"12","author":"LM Warkentin","year":"2014","unstructured":"Warkentin, L. M., Majumdar, S. R., Johnson, J. A., Agborsangaya, C. B., Rueda-Clausen, C. F., Sharma, A. M., et al. (2014). Weight loss required by the severely obese to achieve clinically important differences in health-related quality of life: Two-year prospective cohort study. BMC Medicine, 12, 175. https:\/\/doi.org\/10.1186\/s12916-014-0175-5 .","journal-title":"BMC Medicine"},{"issue":"12","key":"1941_CR41","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1016\/j.spinee.2012.10.006","volume":"12","author":"SL Parker","year":"2012","unstructured":"Parker, S. L., Adogwa, O., Mendenhall, S. K., Shau, D. N., Anderson, W. N., Cheng, J. S., et al. (2012). Determination of minimum clinically important difference (MCID) in pain, disability, and quality of life after revision fusion for symptomatic pseudoarthrosis. The Spine Journal, 12(12), 1122\u20131128. https:\/\/doi.org\/10.1016\/j.spinee.2012.10.006 .","journal-title":"The Spine Journal"},{"issue":"1","key":"1941_CR42","doi-asserted-by":"publisher","first-page":"61","DOI":"10.3171\/2011.8.SPINE1194","volume":"16","author":"SL Parker","year":"2012","unstructured":"Parker, S. L., Mendenhall, S. K., Shau, D., Adogwa, O., Cheng, J. S., Anderson, W. N., et al. (2012). Determination of minimum clinically important difference in pain, disability, and quality of life after extension of fusion for adjacent-segment disease. Journal of Neurosurgery: Spine, 16(1), 61\u201367. https:\/\/doi.org\/10.3171\/2011.8.SPINE1194 .","journal-title":"Journal of Neurosurgery: Spine"},{"issue":"7","key":"1941_CR43","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1016\/j.pain.2013.03.011","volume":"154","author":"J Ashworth","year":"2013","unstructured":"Ashworth, J., Green, D. J., Dunn, K. M., & Jordan, K. P. (2013). Opioid use among low back pain patients in primary care: Is opioid prescription associated with disability at 6-month follow-up? Pain, 154(7), 1038\u20131044. https:\/\/doi.org\/10.1016\/j.pain.2013.03.011 .","journal-title":"Pain"},{"issue":"7","key":"1941_CR44","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1016\/j.jpain.2016.03.006","volume":"17","author":"SK Dobscha","year":"2016","unstructured":"Dobscha, S. K., Lovejoy, T. I., Morasco, B. J., Kovas, A. E., Peters, D. M., Hart, K., et al. (2016). Predictors of improvements in pain intensity in a national cohort of older veterans with chronic pain. The Journal of Pain, 17(7), 824\u2013835. https:\/\/doi.org\/10.1016\/j.jpain.2016.03.006 .","journal-title":"The Journal of Pain"},{"issue":"2 Suppl","key":"1941_CR45","doi-asserted-by":"crossref","first-page":"S105","DOI":"10.36076\/ppj.2008\/11\/S105","volume":"11","author":"R Benyamin","year":"2008","unstructured":"Benyamin, R., Trescot, A. M., Datta, S., Buenaventura, R., Adlaka, R., Sehgal, N., et al. (2008). Opioid complications and side effects. Pain Physician, 11(2 Suppl), S105\u2013S120.","journal-title":"Pain Physician"},{"issue":"6","key":"1941_CR46","doi-asserted-by":"publisher","first-page":"519","DOI":"10.5055\/jom.2015.0305","volume":"11","author":"A Bartoli","year":"2015","unstructured":"Bartoli, A., Michna, E., He, E., & Wen, W. (2015). Pain intensity and interference with functioning and well-being in subgroups of patients with chronic pain treated with once-daily hydrocodone tablets. Journal of Opioid Management, 11(6), 519\u2013533. https:\/\/doi.org\/10.5055\/jom.2015.0305 .","journal-title":"Journal of Opioid Management"},{"issue":"2","key":"1941_CR47","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1111\/acem.12862","volume":"23","author":"B Kea","year":"2016","unstructured":"Kea, B., Fu, R., Lowe, R. A., & Sun, B. C. (2016). Interpreting the national hospital ambulatory medical care survey: United States Emergency Department Opioid Prescribing, 2006\u20132010. Academic Emergency Medicine, 23(2), 159\u2013165. https:\/\/doi.org\/10.1111\/acem.12862 .","journal-title":"Academic Emergency Medicine"}],"container-title":["Quality of Life Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11136-018-1941-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11136-018-1941-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11136-018-1941-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,28]],"date-time":"2022-08-28T01:27:55Z","timestamp":1661650075000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11136-018-1941-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,23]]},"references-count":47,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["1941"],"URL":"https:\/\/doi.org\/10.1007\/s11136-018-1941-1","relation":{},"ISSN":["0962-9343","1573-2649"],"issn-type":[{"value":"0962-9343","type":"print"},{"value":"1573-2649","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,23]]},"assertion":[{"value":"16 July 2018","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2018","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Dr. Hayes was supported by the Translational Training in Addiction [1T32 DA 022981]. Dr. Payakachat received a research grant from 7-Hybrid Cultivation, an honorarium for service as a paid consultant to Roche Ltd., service as a consultant to CBPartners, and ownership of stock in Pfizer. Drs. Hayes and Li declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article utilizes public-use data from the Agency for Healthcare Research and Quality (AHRQ). Therefore, it does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human and animal participants"}}]}}